Oruka Therapeutics, Inc. (ORKA) stock analysis

In our weekly check, Oruka Therapeutics, Inc. is graded F (A to F). Of 17 checks on debt, profit, cash flow and trend: 6 pass, warnings: 2, red flags: 9.

About Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as ORKA.

What our checks show for ORKA

Red flags

Warning signs

Strengths

Similar companies

IMVT · TXG · KOD · TWST · AXSM · ARWR

Questions

What grade does Oruka Therapeutics, Inc. (ORKA) have?

In our weekly check, Oruka Therapeutics, Inc. is graded F (A to F). Of 17 checks on debt, profit, cash flow and trend: 6 pass, warnings: 2, red flags: 9. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of ORKA stock?

This week's biggest flags for Oruka Therapeutics, Inc.: Weak EPS forecast, Weak EPS growth, Thin margins. In total 11 of 17 checks show a warning or a red flag.

What does Oruka Therapeutics, Inc. do?

Oruka Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as ORKA.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis